Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum TripSitter Clinic Ltd C.KETA

Alternate Symbol(s):  TSTTF

TripSitter Clinic Ltd. is a Canada-based company. The Company has no active business.

CSE:KETA - Post Discussion

TripSitter Clinic Ltd > $KETA on day 3 of trading on CSE
View:
Post by StockHawk1 on Dec 01, 2021 6:48pm

$KETA on day 3 of trading on CSE

Day 3 of $KETA.C (TripSitter Clinic Ltd) trading on the CSE!


For those who haven't heard of TripSitter/$KETA yet, it is a company that operates a consultative virtual clinic and telehealth platform in several US states.


$KETA's platform connects those in need to doctors who can evaluate them for a prescribed low-dose ketamine treatment program. 


Their SaaS platform functions as an intermediary that connects prospective patients (many who suffer from PTSD and other mental illnesses) to doctors who can help them through this revolutionary psychedelic treatment. 


Currently $KETA is trading @ $1.21


More on IPO here: 

https://www.newswire.ca/news-releases/tripsitter-to-commence-trading-on-canadian-securities-exchange-802882184.html

 
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities